Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins
Open accessThe DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
Abstract
Statins have been widely used for the treatment of hypercholesterolemia due to their ability to inhibit HMG-CoA reductase, the rate-limiting enzyme of de novo cholesterol synthesis, via the so-called mevalonate pathway. However, their inhibitory action also causes depletion of downstream intermediates of the pathway, resulting in the pleiotropic effects of statins, including the beneficial impact in the treatment of cancer. In our study, we compared the effect of all eight existing statins on the expression of genes, the products of which are implicated in cancer inhibition and suggested the molecular mechanisms of their action in epigenetic and posttranslational regulation, and in cell-cycle arrest, death, migration, or invasion of the cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This pharmacokinetic difference could explain why lipophilic statins have a stronger antiproliferative activity in preclinical systems”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Rimpelová et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“cerivastatin, pitavastatin, and simvastatin had the most significant transcriptomic impact on MIA PaCa-2 PDAC cell line, producing growth arrest and cytoskeletal remodeling, compared to lovastatin, fluvastatin, atorvastatin, pravastatin, and rosuvastatin”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Rimpelová et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Data analysis was performed using the delta–delta Cq method [76] within the R statistical environment [77].”
MethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · cited 1×
“visualized using the Pathview package [74] on the pathways provided by the KEGG database [75].”
MethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · cited 1×
“Three housekeeping genes (RPS9, TBP, and GAPDH) were used as reference genes for RNA quantity normalization using the geNorm algorithm [78].”
MethodPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · cited 1×
“An increased incidence of breast cancer after statin administration was observed in one study [8], but another study did not confirm these findings [9].”
Result(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · cited 2×
“An increased incidence of breast cancer after statin administration was observed in one study [8], but another study did not confirm these findings [9].”
BackgroundResultSCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Autophagy does not always result in programmed cell death, but it represents the important mechanism for catabolic production of ATP during nutrient stress, and also plays an important role in the turnover of proteins and organelles under nutrientreplete conditions [87].”
BackgroundBioMart and Bioconductor: a powerful link between biological databases and microarray data analysis
Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S., De Moor, B., Brazma, A., & Huber, W. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti525 · Cited by 2,315 · cited 1×
“Annotation of differentially expressed transcripts was done with R/BioConductor packages [72] against the Ensembl database (version 47) [73].”
MethodPathview: an R/Bioconductor package for pathway-based data integration and visualization
Luo, W., & Brouwer, C. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt285 · Cited by 2,284 · cited 1×
“visualized using the Pathview package [74] on the pathways provided by the KEGG database [75].”
MethodFraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923 · cited 1×
“In pancreatic adenocarcinoma, both upregulated gene expression of the mevalonate pathway and histone acetylation was detected [47].”
BackgroundStructural mechanism for statin inhibition of HMG-CoA reductase
Istvan, E. S., & Deisenhofer, J. (2001) · Science · doi:10.1126/science.1059344 · Cited by 1,644 · cited 11×
“The inhibition of HMG-CoA conversion to mevalonate caused by HMGCoA reductase inhibition results in the depletion of downstream intermediates of the mevalonate pathway.”
BackgroundInfluentialRidker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261 · cited 1×
“Dysregulation between activities of histone acetyltransferases (HATs) and histone deacetylases (HDACs) is frequent in human tumors [48].”
BackgroundA Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Goldstein, J. L., & Brown, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.01.036 · Cited by 1,233 · cited 1×
“They represent the most prescribed drugs in the treatment of cardiovascular diseases [1].”
BackgroundStatins and the Risk of Colorectal Cancer
Poynter, J. N., Gruber, S. B., Higgins, P. D. R., Almog, R., Bonner, J. D., Rennert, H. S., Low, M., Greenson, J. K., & Rennert, G. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043792 · Cited by 816
Stocker, R., Bowry, V. W., & Frei, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1646 · Cited by 793 · cited 1×
“Except for the metabolism of lipids (biosynthesis of steroids and sphingolipid metabolism), the inhibition of the mevalonate pathway by statins directly affected the energy metabolism due to ubiquinone depletion, as ubiquinone is involved in mitochondrial respiration [80].”
BackgroundKinesin hydrolyses one ATP per 8-nm step
Schnitzer, M. J., & Block, S. M. (1997) · Nature · doi:10.1038/41111 · Cited by 771 · cited 1×
“The active movement of kinesins supports several cellular functions, including mitosis, meiosis, and transport of cargo [68].”
BackgroundThe interplay between cell signalling and the mevalonate pathway in cancer
Mullen, P. J., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.76 · Cited by 699
Hubbard, T. J. P., Aken, B. L., Beal, K., Ballester, B., Caccamo, M., Chen, Y., Clarke, L., Coates, G., Cunningham, F., Cutts, T., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl996 · Cited by 636
Alkylating DNA damage stimulates a regulated form of necrotic cell death
Zong, W.-X., Ditsworth, D., Bauer, D. E., Wang, Z.-Q., & Thompson, C. B. (2004) · Genes & Development · doi:10.1101/gad.1199904 · Cited by 618 · cited 1×
“It is known that failure of these processes could be followed by programmed necrosis [86].”
BackgroundGelsolin, a Multifunctional Actin Regulatory Protein
Sun, H. Q., Yamamoto, M., Mejillano, M., & Yin, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33179 · Cited by 597 · cited 1×
“The activity of gelsolin is stimulated by calcium ions (Ca2+) [67].”
BackgroundWong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 578 · cited 1×
“In contrast, the RhoGDP dissociation inhibitor was downregulated, which was interpreted as a compensatory response [82].”
BackgroundZhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567 · cited 1×
“Lipids, particularly cholesterol, and their derivatives play several roles in tumorigenesis and cancer cell metabolism [37,38].”
BackgroundAthyros, V. G., Papageorgiou, A. A., Mercouris, B. R., Athyrou, V. V., Symeonidis, A. N., Basayannis, E. O., Demitriadis, D. S., & Kontopoulos, A. G. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000787 · Cited by 533
The Risk of Cancer in Users of Statins
Graaf, M. R., Beiderbeck, A. B., Egberts, A. C. G., Richel, D. J., & Guchelaar, H.-J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.027 · Cited by 528 · cited 2×
“Based on other meta-analyses, statins appear to be particularly effective in the chemoprevention of colorectal cancer [10,20].”
BackgroundMethodExpanding Roles for SREBP in Metabolism
Shao, W., & Espenshade, P. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.002 · Cited by 514 · cited 1×
“Moreover, we found that pitavastatin and cerivastatin significantly upregulated the GAS1 (growth arrest-specific gene 1) (data not shown), the product of which positively regulates the Hedgehog signaling [42,43].”
BackgroundSynchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
Keyomarsi, K., Sandoval, L. S., Band, V., & Pardee, A. B. (1991) · PubMed · Cited by 505
Hamelin, B. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01147-4 · Cited by 468
Assmus, B., Urbich, C., Aicher, A., Hofmann, W. K., Haendeler, J., Rössig, L., Spyridopoulos, I., Zeiher, A. M., & Dimmeler, S. (2003) · Circulation Research · doi:10.1161/01.res.0000070067.64040.7c · Cited by 392 · cited 1×
“Moreover, the expression of the cell-cycle inhibitory protein p27 was reduced [90].”
BackgroundCarcinogenicity of Lipid-Lowering Drugs
Newman, T. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530250059028 · Cited by 380
Kawata, S., Yamasaki, E., Nagase, T., Inui, Y., Ito, N., Matsuda, Y., Inada, M., Tamura, S., Noda, S., Imai, Y., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1716 · Cited by 354 · cited 1×
“suffering from hepatocellular carcinoma exhibited statistically significantly longer survival rates for pravastatin therapy [24] than untreated.”
BackgroundRao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345 · cited 1×
“Despite a piece of evidence that lovastatin suppresses cell proliferation through inhibition of proteasome-mediated degradation of p21 and p27 [97], it was concluded that lovastatin neither synchronizes cells nor arrests the cells in the G1 phase of the division cycle [98].”
BackgroundAcetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Carrer, A., Trefely, S., Zhao, S., Campbell, S. L., Norgard, R. J., Schultz, K. C., Sidoli, S., Parris, J. L. D., Affronti, H. C., Sivanand, S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0567 · Cited by 313 · cited 1×
“Finally, to maintain cancer cell proliferation, the increased activation of SREBPs (sterol regulatory element-binding proteins) is required [44]; therefore, SREBP inhibitors are used in molecular-targeted cancer therapies [45,46].”
BackgroundCell cycle-specific effects of lovastatin.
Jakóbisiak, M., Bruno, S., Skierski, J. S., & Darzynkiewicz, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3628 · Cited by 295 · cited 2×
“This was not surprising, as lovastatin is used in the cell-cycle synchronization protocols [92] and as a pharmacological tool for controlling the growth of neoplastic cells both in vitro and in vivo [23,93,94].”
BackgroundThe Role of Statins in Cancer Therapy
Hindler, K., Cleeland, C. S., Rivera, E., & Collard, C. D. (2006) · The Oncologist · doi:10.1634/theoncologist.11-3-306 · Cited by 291
Allen, B. L., Tenzen, T., & McMahon, A. P. (2007) · Genes & Development · doi:10.1101/gad.1543607 · Cited by 284 · cited 1×
“Cholesterol itself serves as a substrate for the post-translational modification of Hedgehog ligands, which is required for their proper trafficking [41].”
BackgroundLovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal, B., Bhendwal, S., Halmos, B., Moss, S. F., Ramey, W. G., & Holt, P. R. (1999) · PubMed · Cited by 251
Actin' up: RhoB in cancer and apoptosis
Prendergast, G. C. (2001) · Nature Reviews Cancer · doi:10.1038/35101096 · Cited by 234 · cited 1×
“tion, RhoB rather appears to act as a negative regulator of these processes [51,52].”
BackgroundLewis, S. J., Sacks, F. M., Mitchell, J. S., East, C., Glasser, S., Kell, S., Letterer, R., Limacher, M., Moye, L. A., Rouleau, J. L., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00202-2 · Cited by 232
Statins Reduce the Risk of Lung Cancer in Humans
Khurana, V., Bejjanki, H. R., Caldito, G., & Owens, M. W. (2007) · Chest · doi:10.1378/chest.06-0931 · Cited by 230 · cited 1×
“war veterans have shown that statin use is associated with a two- to fivefold lower incidence of lung [17], breast [18], and prostate cancers [19].”
BackgroundWen, Y.-A., Xiong, X., Zaytseva, Y. Y., Napier, D. L., Vallee, E., Li, A. T., Wang, C., Weiss, H. L., Evers, B. M., & Gao, T. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0330-6 · Cited by 221 · cited 2×
“Statin-mediated inhibition of sterol synthesis was reported to activate the SREBPs in many tumor types [45].”
BackgroundEven Cancer Cells Watch Their Cholesterol!
Riscal, R., Skuli, N., & Simon, M. C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.008 · Cited by 217 · cited 1×
“Lipids, particularly cholesterol, and their derivatives play several roles in tumorigenesis and cancer cell metabolism [37,38].”
BackgroundGas1 extends the range of hedgehog action by facilitating its signaling
C. Martinelli, D., & Fan, C.-M. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.03.166 · Cited by 217
Chronic Administration of Statins Alters Multiple Gene Expression Patterns in Mouse Cerebral Cortex
Johnson-Anuna, L. N., Eckert, G. P., Keller, J. H., Igbavboa, U., Franke, C., Fechner, T., Schubert-Zsilavecz, M., Karas, M., Müller, W. E., & Wood, W. G. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075028 · Cited by 201 · cited 4×
“On the other hand, it significantly increased the expression of the oncogene c-myc and antiapoptotic gene Bcl-2 [84,85].”
BackgroundResultInfluentialStatins as Anticancer Agents in the Era of Precision Medicine
Longo, J., van Leeuwen, J. E., Elbaz, M., Branchard, E., & Penn, L. Z. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1967 · Cited by 196
Ridley, A. J. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018423.47497.c6 · Cited by 189 · cited 1×
“RHOB, the most dramatically upregulated gene by statins (Table 3), belongs to the Rho protein family of proteins regulating diverse cellular processes, including cytoskeletal organization, gene transcription, cell cycle progression, and cytokinesis [49,50].”
BackgroundLi, X., Chen, Y.-T., Hu, P., & Huang, W.-C. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0797 · Cited by 184 · cited 1×
“Finally, to maintain cancer cell proliferation, the increased activation of SREBPs (sterol regulatory element-binding proteins) is required [44]; therefore, SREBP inhibitors are used in molecular-targeted cancer therapies [45,46].”
BackgroundChimento, A., Casaburi, I., Avena, P., Trotta, F., De Luca, A., Rago, V., Pezzi, V., & Sirianni, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00807 · Cited by 183
Multiple roles for lipids in the Hedgehog signalling pathway
Eaton, S. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2414 · Cited by 160 · cited 1×
“In tumors with deregulated Hedgehog signaling, the depletion of cholesterol results in impairment of Hedgehog signal transduction and inhibition of cancer cell growth [40].”
BackgroundPleiotropic effects of statins: A focus on cancer
Ahmadi, M., Amiri, S., Pecic, S., Machaj, F., Rosik, J., Łos, M. J., Alizadeh, J., Mahdian, R., da Silva Rosa, S. C., Schaafsma, D., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165968 · Cited by 159
Wang, G., Cao, R., Wang, Y., Qian, G., Dan, H. C., Jiang, W., Ju, L., Wu, M., Xiao, Y., & Wang, X. (2016) · Scientific Reports · doi:10.1038/srep35783 · Cited by 152
Cytoskeletal Activation and Altered Gene Expression in Endothelial Barrier Regulation by Simvastatin
Jacobson, J. R., Dudek, S. M., Birukov, K. G., Ye, S. Q., Grigoryev, D. N., Girgis, R. E., & Garcia, J. G. N. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0267oc · Cited by 152
A Phase I-II Trial of Lovastatin for Anaplastic Astrocytoma and Glioblastoma Multiforme
Larner, J. M., Jane, J., Laws, E. R., Packer, R. J., Myers, C. E., & Shaffrey, M. E. (1998) · American Journal of Clinical Oncology · doi:10.1097/00000421-199812000-00010 · Cited by 142 · cited 1×
“On the other hand, beneficial effects of lovastatin therapy on the survival rate of patients suffering from glioblastoma multiforme or advanced gastric adenocarcinoma have not been observed [25,26].”
BackgroundPhase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma
Kim, W. S., Kim, M. M., Choi, H. J., Yoon, S., Lee, M. H., Park, K., Park, C. H., & Kang, W. K. (2001) · Investigational New Drugs · doi:10.1023/a:1006481423298 · Cited by 137
The TP53INP2 Protein Is Required for Autophagy in Mammalian Cells
Nowak, J., Archange, C., Tardivel-Lacombe, J., Pontarotti, P., Pébusque, M.-J., Vaccaro, M. I., Velasco, G., Dagorn, J.-C., & Iovanna, J. L. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0671 · Cited by 134 · cited 1×
“R-Ras promotes the formation of focal adhesions, cell spreading, and activation of integrins [53].”
BackgroundDenoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 128 · cited 1×
“In the next study, downregulation of cyclin D1, PCNA, and c-myc, and upregulation of p21 and p19, were provided by the treatment of human breast cancer cells with cerivastatin [91].”
BackgroundDifferences in antitumor effects of various statins on human pancreatic cancer
Gbelcová, H., Leníček, M., Zelenka, J., Knejzlík, Z., Dvořáková, G., Zadinová, M., Poučková, P., Kudla, M., Balaž, P., Ruml, T., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23242 · Cited by 110 · cited 10×
“The setting of the experimental conditions of the present study was based on the results of our previous published studies [30,31], in which we reported on the differences in the individual anticancer potential of individual statins in cells derived from pancreatic carcinoma.”
BackgroundMethodResultInfluentialSelf-citationThe Innovative Potential of Statins in Cancer: New Targets for New Therapies
Di Bello, E., Zwergel, C., Mai, A., & Valente, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00516 · Cited by 105
Menter, D. G., Ramsauer, V. P., Harirforoosh, S., Chakraborty, K., Yang, P., Hsi, L., Newman, R. A., & Krishnan, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028813 · Cited by 100
Kidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., et al. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-127 · Cited by 99
The differential effects of statins on the metastatic behaviour of prostate cancer
Brown, M., Hart, C., Tawadros, T., Ramani, V, Sangar, V, Lau, M., & Clarke, N. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.138 · Cited by 94
Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin
Hawk, M. A., Cesen, K. T., Siglin, J. C., Stoner, G. D., & Ruch, R. J. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04465-5 · Cited by 87 · cited 1×
“While there have been several in vitro and in vivo studies directly targeting and confirming the marked effect of statins on the growth of a wide variety of tumor types, such as hepatocellular [21], lung [22], and colorectal carcinoma [23], clinical trials targeting statin efficacy in cancer treatment have been very r…”
BackgroundMaltese, W. A., & Sheridan, K. M. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041250326 · Cited by 86 · cited 2×
“This was not surprising, as lovastatin is used in the cell-cycle synchronization protocols [92] and as a pharmacological tool for controlling the growth of neoplastic cells both in vitro and in vivo [23,93,94].”
BackgroundNK-104: a novel synthetic HMG-CoA reductase inhibitor
Kajinami, K., Mabuchi, H., & Saito, Y. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2653 · Cited by 85
Bonovas, S., Filioussi, K., & Sitaras, N. M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02051.x · Cited by 81 · cited 1×
“The findings of the meta-analyses suggested an association between pravastatin treatment and cancer in elderly patients [27] but did not support the potential role of statins in the prevention of hematological malignancies [28] or the hypothesis that statins reduce the risk of pancreatic cancer development [29].”
ResultStatin Use and Risk of Pancreatic Cancer: An Updated Meta-analysis of 26 Studies
Zhang, Y., Liang, M., Sun, C., Qu, G., Shi, T., Min, M., Wu, Y., & Sun, Y. (2019) · Pancreas · doi:10.1097/mpa.0000000000001226 · Cited by 81 · cited 1×
“We focused on the pancreatic cancer cells because, in the very recent meta-analysis of 26 studies containing more than 3 million participants and 170,000 pancreatic cancer patients, statin therapy was shown to significantly reduce the risk of pancreatic cancer [36].”
BackgroundDeterminants of sensitivity to lovastatin-induced apoptosis in multiple myeloma
Wong, W. W.-L., Clendening, J. W., Martirosyan, A., Boutros, P. C., Bros, C., Khosravi, F., Jurisica, I., Stewart, A. K., Bergsagel, P. L., & Penn, L. Z. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0745 · Cited by 79 · cited 1×
“demonstrated that only 8 of 17 multiple myeloma cell lines evaluated were sensitive to lovastatin-induced apoptosis, while resistant cell lines had different genetic profiles [81].”
BackgroundGeranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells
Mazières, J., Tillement, V., Allal, B., Clanet, C., Bobin, L., Chen, Z., Sebti, S. M., Favre, G., & Pradines, A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.019 · Cited by 75 · cited 1×
“RHOB, the most dramatically upregulated gene by statins (Table 3), belongs to the Rho protein family of proteins regulating diverse cellular processes, including cytoskeletal organization, gene transcription, cell cycle progression, and cytokinesis [49,50].”
BackgroundTAVINTHARAN, S., Ong, C. N., Jeyaseelan, K., Sivakumar, M., Lim, S. K., & Sum, C. F. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.013 · Cited by 71 · cited 1×
“From these, FPP and GGPP play an important role in the posttranslational modification of cellular proteins involved in cell division and differentiation, gene expression, cytoskeleton formation, intracellular protein and lipid transport, and defense against pathogens [4].”
BackgroundStatins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
Gordon, R. E., Zhang, L., Peri, S., Kuo, Y.-M., Du, F., Egleston, B. L., Ng, J. M. Y., Andrews, A. J., Astsaturov, I., Curran, T., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2923 · Cited by 70 · cited 1×
“On the other hand, statins are responsible for a decrease in the cholesterol content in lipid rafts by inhibiting the mevalonate pathway and, thus, induce apoptosis via inhibition of the Akt signaling pathway [39].”
BackgroundExplaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations
da Costa, R. F., Freire, V. N., Bezerra, E. M., Cavada, B. S., Caetano, E. W. S., de Lima Filho, J. L., & Albuquerque, E. L. (2012) · Phys. Chem. Chem. Phys. · doi:10.1039/c1cp22824b · Cited by 69 · cited 1×
“, binding energies of 320, 310, 290, and 290 kcal·mol-1, respectively [99].”
BackgroundThe C-terminal end of R-Ras contains a focal adhesion targeting signal
Furuhjelm, J., & Peränen, J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00689 · Cited by 68
Kawata, S., Nagase, T., Yamasaki, E., Ishiguro, H., & Matsuzawa, Y. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.199 · Cited by 64 · cited 1×
“While there have been several in vitro and in vivo studies directly targeting and confirming the marked effect of statins on the growth of a wide variety of tumor types, such as hepatocellular [21], lung [22], and colorectal carcinoma [23], clinical trials targeting statin efficacy in cancer treatment have been very r…”
BackgroundCYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis
Fromigué, O., Hamidouche, Z., Vaudin, P., Lecanda, F., Patiño‐García, A., Barbry, P., Mari, B. P., & Marie, P. J. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.343 · Cited by 62
Ghosh, P., Mott, G. E., Ghosh‐Choudhury, N., Radnik, R. A., Stapleton, M. L., Ghidoni, J. J., & Kreisberg, J. I. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00091-8 · Cited by 61 · cited 1×
“The G1 block has been attributed to the inhibition of either cytokinesis or cell spreading following cytokinesis [95].”
BackgroundCorpataux, J.-M., Naik, J., Porter, K. E., & London, N. J. M. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2005.05.016 · Cited by 57
Does pravastatin promote cancer in elderly patients? A meta-analysis
Bonovas, S., & Sitaras, N. M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060803 · Cited by 55 · cited 1×
“The findings of the meta-analyses suggested an association between pravastatin treatment and cancer in elderly patients [27] but did not support the potential role of statins in the prevention of hematological malignancies [28] or the hypothesis that statins reduce the risk of pancreatic cancer development [29].”
ResultAbsolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück, W. M., Ritter, W., Ochmann, K., Unger, S., Ahr, G., Wingender, W., & Kuhlmann, J. (1997) · PubMed · Cited by 53
Variability in statin-induced changes in gene expression profiles of pancreatic cancer
Gbelcová, H., Rimpelová, S., Ruml, T., Fenclová, M., Kosek, V., Hajšlová, J., Strnad, H., Kolář, M., & Vítek, L. (2017) · Scientific Reports · doi:10.1038/srep44219 · Cited by 48 · cited 5×
“The setting of the experimental conditions of the present study was based on the results of our previous published studies [30,31], in which we reported on the differences in the individual anticancer potential of individual statins in cells derived from pancreatic carcinoma.”
BackgroundMethodResultInfluentialSelf-citationDoes Lowering Cholesterol Cause Cancer?
Dalen, J. E. (1996) · JAMA · doi:10.1001/jama.1996.03530250071030 · Cited by 44 · cited 2×
“However, the dose of statins administered in that study was very high and not applicable for humans [7].”
BackgroundStatins to reduce breast cancer risk: A case control study in U.S. female veterans
Kochhar, R., Khurana, V., Bejjanki, H. R., Caldito, G. C., & Fort, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.514 · Cited by 41 · cited 1×
“war veterans have shown that statin use is associated with a two- to fivefold lower incidence of lung [17], breast [18], and prostate cancers [19].”
BackgroundStatins: Complex outcomes but increasingly helpful treatment options for patients
Mohammadkhani, N., Gharbi, S., Rajani, H. F., Farzaneh, A., Mahjoob, G., Hoseinsalari, A., & Korsching, E. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172704 · Cited by 38 · cited 2×
“, farnesyl pyrophosphate (FPP), geranylgeranyl pyrophosphate (GGPP), isopentenyl adenine, dolichol, and the polyisoprenoid side chains of heme A and ubiquinone, which are essential molecules that play a vital role in almost any cell process [3].”
BackgroundThe Proteasomal and Autophagic Pathways Converge on Lipid Droplets
Fujimoto, T., & Ohsaki, Y. (2006) · Autophagy · doi:10.4161/auto.2904 · Cited by 37 · cited 1×
“Interestingly, it was published that ubiquitinated hydrophobic proteins that are prone to aggregation are kept on the surface of lipid droplets and subjected to autophagy, as well as proteasomal degradation [88].”
BackgroundREAPPRAISAL OF G1‐PHASE ARREST AND SYNCHRONIZATION BY LOVASTATIN
Cooper, S. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0925 · Cited by 36
Bonovas, S., Filioussi, K., Tsantes, A. Ε., & Sitaras, N. M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02959.x · Cited by 32 · cited 1×
“The findings of the meta-analyses suggested an association between pravastatin treatment and cancer in elderly patients [27] but did not support the potential role of statins in the prevention of hematological malignancies [28] or the hypothesis that statins reduce the risk of pancreatic cancer development [29].”
ResultSheng, S., Barnett, D., & Katzenellenbogen, B. S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.022 · Cited by 28 · cited 2×
“For example, expression of keratin 13 is known to be regulated by nuclear receptor ligands such as retinoids, 1α, 25-dihydroxy vitamin D3, or estrogen [65].”
BackgroundRelation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas
Adamkov, M., Halášová, E., Rajčáni, J., Bencat, M., Výbohová, D., Rybárová, S., & Galbavy, S. (2011) · Medical Science Monitor · doi:10.12659/msm.881442 · Cited by 27 · cited 2×
“On the other hand, it significantly increased the expression of the oncogene c-myc and antiapoptotic gene Bcl-2 [84,85].”
BackgroundYang, Y., Huang, W., Chuan, L.-M., Xiao, D.-W., Zeng, Y., Zhou, D.-A., Xu, G., Liu, W., Huang, B., & Hu, Q. (2008) · Chemotherapy · doi:10.1159/000158663 · Cited by 27 · cited 1×
“The results of flow cytometry showed that the cell cycle was arrested in the G1 phase [89].”
BackgroundThe role of statins as therapeutic agents in cancer
Sopková, J., Vidomanová, E., Strnádel, J., Škovierová, H., & Halášová, E. (2017) · General Physiology and Biophysics · doi:10.4149/gpb_2017045 · Cited by 26
Statins and prostate cancer risk: A large case control study in veterans
Singal, R., Khurana, V., Caldito, G. C., & Fort, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.1004 · Cited by 24
Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Feleszko, W., & Jakóbisiak, M. (2000) · PubMed · Cited by 23
Briefly about Anticancer Properties of Statins
Alexandrova, R. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.17.002975 · Cited by 5 · cited 1×
“Currently, there are eight existing statins, namely atorvastatin, cerivastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin [2].”
BackgroundA Non-Characteristic Response of L1210 Cells to Lovastatin
Engelke, K. J., & Hacker, M. P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2196 · Cited by 5 · cited 1×
“Several authors have also noted the retardation or arrest of the cell cycle at the G2/M transition [93,94,96].”
BackgroundSvoboda, M., Vyskocil, J., & Nováková, J. (2006) · Klinická farmakologie a farmacie · Cited by 1
Research works printed but not linked: 10
- (2021, February 09). NCBI, Available online: https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=4998.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=983.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=994.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=6502.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1870.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=8793.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=7138.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=3728.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=7430.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1008.
Cited by
Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E., & Kiemer, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212480 · Cited by 26
“Interestingly, cerivastatin has been shown to reduce the expression of genes involved in the MVA pathway to a higher degree than simvastatin [45], implying that this pathway may be especially vulnerable to cerivastatin-mediated interference.”
BackgroundCerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma
Amaro, A. A., Gangemi, R. M. R., Emionite, L., Castagnola, P., Filaci, G., Jager, M. J., Tanda, E. T., Spagnolo, F., Mascherini, M., Pfeffer, U., et al. (2023) · Cancers · doi:10.3390/cancers15030886 · Cited by 17
“Upregulation of KRAS likely reflects the low levels of post-translationally modified KRAS protein due to the inhibition of the mevalonate pathway by cerivastatin [47,53,54].”
BackgroundInfluentialChoi, Y. S., Cho, H. J., & Jung, H. J. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.5.367 · Cited by 11
“Statins are potent competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR), which is a rate-limiting enzyme in the mevalonate pathway, approved by the Food and Drug Administration (FDA) as a lipid-lowering drug [9].”
BackgroundDuttenhefner, J. N., & Reindl, K. M. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.004 · Cited by 6
Marzoog, B. A., & Kopylov, F. Y. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46903 · Cited by 6
Metadata
- Authors
- Rimpelová, S., Kolář, M., Strnad, H., Ruml, T., Vítek, L., & Gbelcová, H.
- Affiliations
- University of Chemistry and Technology, Prague (CZ)
- Czech Academy of Sciences (CZ)
- Institute of Medical Biochemistry and Laboratory Diagnostics, and 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic
- Comenius University Bratislava (SK)
- Corresponding author
- Rimpelová, Silvie
- Gbelcová, Helena
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-06-09
- Volume
- 26
- Issue
- 12
- Pages
- 3528
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8226792
- OpenAlex
- W3171878125
- Cited by
- 8
- References
- 98
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Operational Programme Research, Development and Education (No. CZ.02.1.01/0.0/0.0/16_019/0000785)
- the Slovak Research and Development Agency (APVV-15-0217)
- the Czech Ministry of Health (RVO-VFN64165/2021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- statins, pancreatic cancer, MIA PaCa-2 cells, gene expression profiling, HMG-CoA reductase inhibition, mevalonate pathway, pleiotropic effects of statins, gene expression, epigenetic regulation, post-translational regulation, cell cycle arrest, cell death, cell migration, cell invasion, anticancer effects
- MeSH terms
- Antineoplastic Agents, Cell Movement, Humans, Mevalonic Acid, Pancreatic Neoplasms, Cell Death, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Computational Biology, Epigenesis, Genetic, Cell Line, Tumor, Cell Proliferation, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.